Back to search

Article

Abatacept-based Graft-Versus-Host-Disease Prophylaxis in Haplo-identical Hematopoietic Cell Transplant: Single Center Experience in a High-Risk Cohort

2021-06-25

Abstract excerpt

Post-transplant cyclophosphamide (PTCy) has become the most popular approach in haplo-identical hematopoietic cell transplant (haplo-HCT). Although there are reports of a small number of adult patients in the literature who experienced graft failure and were re-transplanted with a haploidentical donor with PTCy prophylaxis, there is still insufficient guidance for patients with specific contraindications/complicat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52f2703b-d8e2-52f1-ab79-791f68fafdad
DOI
10.22541/au.162465134.42493117/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Abatacept-based Graft-Versus-Host-Disease Prophylaxis in Haplo-identical Hematopoietic Cell Transplant: Single Center Experience in a High-Risk CohortDOI 10.22541/au.162465134.42493117/v1
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppressionSemantic proximity
Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and TreatmentSemantic proximity
Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor.Semantic proximity
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disordersSemantic proximity
Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation.Semantic proximity
Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric PatientsSemantic proximity
Posttransplant cyclophosphamide in HLA-matched and 1-2 allele mismatched peripheral blood stem cell transplantationSemantic proximity
The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders.Semantic proximity
A Single Institution Experience of Bortezomib for GVHD in a Pediatric HSCT PopulationSemantic proximity
Successful Haploidentical Transplant Using Post-Transplant Cyclophosphamide in a Child with Chronic Granulomatous Disease-First Report from the Indian Subcontinent.Semantic proximity
Feasibility of HLA-Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Advanced Pediatric MalignanciesSemantic proximity
Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experienceSemantic proximity
Select a neighboring publication to make it the new centre.